rs143820618

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting

The NM_139343.3(BIN1):​c.696C>A​(p.Asn232Lys) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000542 in 1,613,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00036 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00056 ( 0 hom. )

Consequence

BIN1
NM_139343.3 missense, splice_region

Scores

1
11
6
Splicing: ADA: 0.8781
1
1

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:8B:1O:1

Conservation

PhyloP100: 1.87

Publications

6 publications found
Variant links:
Genes affected
BIN1 (HGNC:1052): (bridging integrator 1) This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, synaptojanin, endophilin, and clathrin. Isoforms that are expressed in muscle and ubiquitously expressed isoforms localize to the cytoplasm and nucleus and activate a caspase-independent apoptotic process. Studies in mouse suggest that this gene plays an important role in cardiac muscle development. Alternate splicing of the gene results in several transcript variants encoding different isoforms. Aberrant splice variants expressed in tumor cell lines have also been described. [provided by RefSeq, Mar 2016]
BIN1 Gene-Disease associations (from GenCC):
  • centronuclear myopathy
    Inheritance: AD, AR, SD Classification: DEFINITIVE, LIMITED Submitted by: ClinGen
  • myopathy, centronuclear, 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • autosomal dominant centronuclear myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.20332357).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000361 (55/152352) while in subpopulation NFE AF = 0.000661 (45/68040). AF 95% confidence interval is 0.000507. There are 0 homozygotes in GnomAd4. There are 28 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139343.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BIN1
NM_139343.3
MANE Select
c.696C>Ap.Asn232Lys
missense splice_region
Exon 8 of 19NP_647593.1O00499-1
BIN1
NM_001320642.1
c.615C>Ap.Asn205Lys
missense splice_region
Exon 8 of 19NP_001307571.1O00499
BIN1
NM_001320641.2
c.603C>Ap.Asn201Lys
missense splice_region
Exon 7 of 18NP_001307570.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BIN1
ENST00000316724.10
TSL:1 MANE Select
c.696C>Ap.Asn232Lys
missense splice_region
Exon 8 of 19ENSP00000316779.5O00499-1
BIN1
ENST00000357970.7
TSL:1
c.696C>Ap.Asn232Lys
missense splice_region
Exon 8 of 18ENSP00000350654.3O00499-5
BIN1
ENST00000346226.7
TSL:1
c.603C>Ap.Asn201Lys
missense splice_region
Exon 7 of 16ENSP00000315411.3O00499-2

Frequencies

GnomAD3 genomes
AF:
0.000361
AC:
55
AN:
152234
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000661
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000426
AC:
107
AN:
251286
AF XY:
0.000419
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000766
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000561
AC:
820
AN:
1461394
Hom.:
0
Cov.:
34
AF XY:
0.000547
AC XY:
398
AN XY:
727036
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33476
American (AMR)
AF:
0.000380
AC:
17
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.0000754
AC:
4
AN:
53024
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000698
AC:
776
AN:
1111944
Other (OTH)
AF:
0.000348
AC:
21
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
48
95
143
190
238
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000361
AC:
55
AN:
152352
Hom.:
0
Cov.:
33
AF XY:
0.000376
AC XY:
28
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41570
American (AMR)
AF:
0.000327
AC:
5
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000661
AC:
45
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000597
Hom.:
0
Bravo
AF:
0.000408
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000387
AC:
47
EpiCase
AF:
0.000491
EpiControl
AF:
0.00101

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
5
-
Myopathy, centronuclear, 2 (6)
-
3
-
not provided (3)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Benign
-0.30
T
BayesDel_noAF
Benign
-0.30
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.70
D
Eigen
Uncertain
0.45
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.94
D
M_CAP
Benign
0.060
D
MetaRNN
Benign
0.20
T
MetaSVM
Benign
-0.67
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
1.9
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-3.9
D
REVEL
Benign
0.26
Sift
Uncertain
0.0050
D
Sift4G
Uncertain
0.027
D
Polyphen
1.0
D
Vest4
0.43
MutPred
0.46
Gain of methylation at N232 (P = 0.0192)
MVP
0.85
MPC
0.98
ClinPred
0.39
T
GERP RS
3.4
Varity_R
0.53
gMVP
0.79
Mutation Taster
=37/63
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.88
dbscSNV1_RF
Pathogenic
0.73
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143820618; hg19: chr2-127821511; API